A novel integrated system using patient-derived glioma cerebral organoids and xenografts for disease modeling and drug screening.
Zhang L, Liu F, Weygant N, Zhang J, Hu P, Qin Z, Yang J, Cheng Q, Fan F, Zeng Y, Tang Y, Li Y, Tang A, He F, Peng J, Liao W, Hu Z, Li M, Liu Z.
Zhang L, et al. Among authors: cheng q.
Cancer Lett. 2021 Mar 1;500:87-97. doi: 10.1016/j.canlet.2020.12.013. Epub 2020 Dec 10.
Cancer Lett. 2021.
PMID: 33309780